Newsroom

Press image
News
To ensure that vaccines provide strong and lasting immunization, it is often necessary to supplement the actual vaccine (antigen) with additives that stimulate the immune system: adjuvants. Today, only a few substances have been approved for use as adjuvants. In the journal Angewandte Chemie, a research team has now introduced a spectrum of potential adjuvants. They started with the immune stimulant α-glactosyl ceramide (α-GalCer) and synthesized many different variants from a set of four building blocks.
04.12.2023
Tabletten
News
The Federal Ministry of Education and Research (BMBF) is funding the establishment of a German-Ukrainian core of excellence to help discover new anti-infectives and make them available for medical purposes. The core of excellence, funded with 2.5 million euros, is to be located in the western Ukrainian city of Lviv - in collaboration with Saarland University and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). In the long term, the core of excellence should establish itself as an independent research institution and strengthen scientific relations between Germany and Ukraine. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with Saarland University.
28.11.2023
AI Image symbolique, personne en blouse blanche avec stéthoscope en arrière-plan
News
Improving health care and strengthening personalized medicine: A new research center for Artificial Intelligence (AI) and causal methods in medicine (CAIMed - Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine) is being established in Lower Saxony. Researchers in computer science and medicine from Hannover, Göttingen and Braunschweig will develop innovative methods and applications of artificial intelligence. The Ministry of Science and Culture and the Volkswagen Foundation are providing 15 million euros from the joint "zukunft.niedersachsen" program for the next five years. Prof Wolfgang Nejdl from the L3S Research Centre at the Leibniz University of Hanover (LUH) will act as spokesperson. Two of the new research groups will be set up at sites of the Helmholtz Centre for Infection Research (HZI).
22.11.2023
Portrait of researchers
News
The list of “Highly-cited researchers” is published annually by Clarivate Analytics to honor scientists who have made a particularly significant impact in their fields. Five heads of department at the Helmholtz Centre for Infection Research (HZI) are among the honorees in 2023: bioinformaticians Prof Alice McHardy, Prof Yang Li and Prof Andreas Keller, biotechnologist Prof Marc Stadler and the Scientific Director of the HZI and geneticist Prof Josef Penninger were recognized for their scientific publications in the past year.
17.11.2023
chart
News
Sustainable and environmentally friendly production processes are playing an increasingly important role in almost all branches of industry. The production of active pharmaceutical ingredients in particular involves the use of various materials and reagents, many of which have environmentally harmful properties and therefore require costly processing and disposal. Researchers at the University of Graz and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now succeeded in developing a strategy for the synthesis of active pharmaceutical ingredients from wood waste that does not involve any harmful starting materials or by-products. The team published its results in the journal Angewandte Chemie International Edition.
16.11.2023
Picture of the current DZIF Executive Board
News
Professor Thomas Pietschmann, Scientific Co-Director of the Helmholtz Centre for Infection Research (HZI), Professor of Experimental Virology at Hannover Medical School (MHH) and virologist at TWINCORE - Centre for Experimental and Clinical Infection Research—a joint institution of the MHH and the HZI—has been elected to the DZIF Executive Board by the members of the German Center for Infection Research (DZIF). Pietschmann's term of office begins on 8 November 2023.
09.11.2023

HZI in the media

before and we just didn’t notice?” asks Fabian Leendertz, director of the Helmholtz Institute for One Health. He points out that wildlife

25.06.2025
|
Resurgence

... Samonellen liegen unter Schwarzlicht im Labor des Helmholtz-Zentrums in Braunschweig. Foto: Peter Steffen/dpa ...

23.06.2025
|
Kurier

Slevogt from the MHH and the Helmholtz Centre for Infection Research (“Helmholtz-Zentrum für Infektionsforschung“; HZI). An application for

23.06.2025
|
Trading View

... der Universität des Saarlandes , des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS) und internationalen Teams ...

19.06.2025
|
CHIP

Forschende am Helmholtz-Zentrum für Infektionsforschung in Braunschweig (Niedersachsen) arbeiten an einer neuer Impfstoff-Technologie, die

18.06.2025
|
17:30 SAT.1 REGIONAL

... machen

 

Die Studie der Wissenschaftler des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig will daher vor ...

18.06.2025
|
Cityblick 24

including Dr. Max Kellner and Prof.‌ Josef Penninger of the⁢ Helmholtz Center for Infection Research (HZI), explored this ‌resilience.They

17.06.2025
|
Newsdirectory3

the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Chair of Microbiology of the Julius-Maximilians-Universität Würzburg

17.06.2025
|
Phys.org

Instituts für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) ...

17.06.2025
|
DeutschesGesundheitsPortal

Register now for the HZI-Newsletter

and stay up to date!

CAPTCHA image for SPAM prevention If you can't read the word, click here.